El Salvador revokes ISSS private-contracting ban:
This article was originally published in Clinica
Executive Summary
El Salvador's supreme court of justice has revoked a new law banning its main public healthcare provider, the national social security institute (ISSS), from using the private sector. Capris Division Medica of Costa Rica and Serconse of San Salvador had appealed against article 5 of the polemical decree 1.024 of November 14, which ordered all contracts to be terminated by the end of 2002.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.